Gene therapy sector heating up with first FDA approval
RNAI-First approval today
Our partners all seem to be doing well i.e Calimmune sold, sparks doing well etc.
Rare Orphan Drug status popular more than ever... i.e (OPMD)
We are collaborating with partners in developing CAR-T an area where money is pouring in.
If we can't do a deal now then when!